Akeso 주식 주식분석 | 주식가격 | 뉴스 | 9926.HK | KYG0146B1032 | A2P200

날짜	Akeso 주식 가격
	61.29 undefined
	62.79 undefined
	60.98 undefined
	61.82 undefined
	63.30 undefined
	63.67 undefined
	62.51 undefined
	57.50 undefined
	60.25 undefined
	62.72 undefined
	63.25 undefined
	63.70 undefined
	62.01 undefined
	63.60 undefined
	60.49 undefined
	61.37 undefined
	63.25 undefined
	62.26 undefined
	60.38 undefined
	59.49 undefined
	58.90 undefined

날짜	Akeso 매출	Akeso EBIT	Akeso 이익
2030e	12.64 조. undefined	4.74 조. undefined	0 undefined
2029e	11.68 조. undefined	4 조. undefined	0 undefined
2028e	10.89 조. undefined	4.64 조. undefined	0 undefined
2027e	7.85 조. undefined	3.08 조. undefined	2.15 조. undefined
2026e	6.18 조. undefined	1.43 조. undefined	1.33 조. undefined
2025e	4.18 조. undefined	375.08 백만 undefined	243.91 백만 undefined
2024e	2.65 조. undefined	-370.92 백만 undefined	-406.81 백만 undefined
2023	4.53 조. undefined	2.05 조. undefined	2.03 조. undefined
2022	837.66 백만 undefined	-1.38 조. undefined	-1.17 조. undefined
2021	225.63 백만 undefined	-1.28 조. undefined	-1.07 조. undefined
2020	0 undefined	-1.37 조. undefined	-1.04 조. undefined
2019	70.88 백만 undefined	-345.35 백만 undefined	-335.39 백만 undefined
2018	2.83 백만 undefined	-157.01 백만 undefined	-142.31 백만 undefined

	매출	EBIT	이익
2018	2.83 백만 CNY	-157.01 백만 CNY	-142.31 백만 CNY
2019	70.88 백만 CNY	-345.35 백만 CNY	-335.39 백만 CNY
2020	0 CNY	-1.37 조. CNY	-1.04 조. CNY
2021	225.63 백만 CNY	-1.28 조. CNY	-1.07 조. CNY
2022	837.66 백만 CNY	-1.38 조. CNY	-1.17 조. CNY
2023	4.53 조. CNY	2.05 조. CNY	2.03 조. CNY
2024e	2.65 조. CNY	-370.92 백만 CNY	-406.81 백만 CNY
2025e	4.18 조. CNY	375.08 백만 CNY	243.91 백만 CNY
2026e	6.18 조. CNY	1.43 조. CNY	1.33 조. CNY
2027e	7.85 조. CNY	3.08 조. CNY	2.15 조. CNY
2028e	10.89 조. CNY	4.64 조. CNY	0 CNY
2029e	11.68 조. CNY	4 조. CNY	0 CNY
2030e	12.64 조. CNY	4.74 조. CNY	0 CNY

2018	2019	2020	2021	2022	2023	2024e	2025e	2026e	2027e	2028e	2029e	2030e
0	0.07	0	0.23	0.84	4.53	2.65	4.18	6.18	7.85	10.89	11.68	12.64
-	3,400.00	-	-	272.00	440.74	-41.38	57.56	47.80	27.06	38.66	7.29	8.19
100.00	100.00	-	86.67	87.69	96.95	-	-	-	-	-	-	-
0	0.07	0	0.2	0.73	4.39	0	0	0	0	0	0	0
-0.16	-0.35	-1.37	-1.28	-1.38	2.05	-0.37	0.38	1.43	3.08	4.64	4	4.74
-7,850.00	-492.86	-	-566.67	-164.40	45.27	-13.95	8.97	23.10	39.22	42.65	34.26	37.55
-0.14	-0.34	-1.04	-1.07	-1.17	2.03	-0.41	0.24	1.33	2.15	0	0	0
-	135.92	209.25	3.67	8.75	-273.63	-120.02	-159.85	446.09	61.72	-	-	-
603.64	603.64	628.94	815.93	824.99	837.82	0	0	0	0	0	0	0
-	-	-	-	-	-	-	-	-	-	-	-	-

2018	2019	2020	2021	2022

0.41	1.19	2.79	2.64	2.29
0	0	0	101.5	271.05
0	0	0	179.69	121.47
16.97	15.52	61.24	196.62	341.83
5.8	14.94	46.34	32.82	35.82
0.44	1.22	2.9	3.15	3.06
0.19	0.32	0.85	1.65	2.41
0	0	0	0	10
0	0	0	0	0
0.2	99.76	1.23	3.98	8.5
0	0	0	0	0
0	0	0	0	8.74
0.19	0.42	0.85	1.65	2.44
0.63	1.63	3.76	4.81	5.5

0	34	55	57	59
0	0	2.63	4.01	4.59
439.05	-6.49	785.73	-505.81	-1,792.92
2.17	0.1	-231.83	-337.24	-156.89
0	0	0	0	0
0.44	-0.01	3.19	3.16	2.64
47.35	42.92	112.61	206.32	308.95
6.94	17.38	34.95	87.24	134.43
4.95	18.51	5.74	308.69	465.89
0	0	0	0	0
26.99	40.95	16.68	53.45	451.88
0.09	0.12	0.17	0.66	1.36
0.04	1.28	0.18	0.81	1.43
0	0	0	0	0
39.33	60.15	53.44	63.86	159.57
0.08	1.34	0.24	0.87	1.59
0.16	1.46	0.41	1.53	2.95
0.6	1.45	3.59	4.69	5.58

2018	2019	2020	2021	2022
-154	-346	-1,320	-1,258	-1,422
12	16	22	58	105
0	50	0	0	0
30	43	-7	121	82
-12	66	687	77	-6
2	4	3	12	55
0	0	0	0	0
-123	-219	-617	-1,001	-1,240
-74	-136	-448	-716	-802
-26	-127	-555	-579	-889
47	8	-107	136	-87
0	0	0	0	0
29	83	33	638	995
0	1.21	2.71	0.94	0.5
0.25	1.23	2.88	1.59	1.49
216	-60	130	7	-10
0	0	0	0	0
0.1	0.87	1.5	-0.04	-0.55
-197.57	-356.28	-1,066.25	-1,717.35	-2,042.91
0	0	0	0	0

Akeso 브루토마진	Akeso 이익 마진	Akeso EBIT-마진	Akeso 이익 마진
2030e	96.96 %	37.55 %	0 %
2029e	96.96 %	34.26 %	0 %
2028e	96.96 %	42.65 %	0 %
2027e	96.96 %	39.22 %	27.34 %
2026e	96.96 %	23.1 %	21.48 %
2025e	96.96 %	8.97 %	5.84 %
2024e	96.96 %	-13.98 %	-15.33 %
2023	96.96 %	45.28 %	44.81 %
2022	87.69 %	-164.34 %	-139.48 %
2021	86.61 %	-565.4 %	-476.42 %
2020	96.96 %	0 %	0 %
2019	100 %	-487.24 %	-473.18 %
2018	100 %	-5,555.87 %	-5,035.63 %

	브루토마진	EBIT-마진	이익 마진
2018	100 %	-5,555.87 %	-5,035.63 %
2019	100 %	-487.24 %	-473.18 %
2020	96.96 %	0 %	0 %
2021	86.61 %	-565.4 %	-476.42 %
2022	87.69 %	-164.34 %	-139.48 %
2023	96.96 %	45.28 %	44.81 %
2024e	96.96 %	-13.98 %	-15.33 %
2025e	96.96 %	8.97 %	5.84 %
2026e	96.96 %	23.1 %	21.48 %
2027e	96.96 %	39.22 %	27.34 %
2028e	96.96 %	42.65 %	0 %
2029e	96.96 %	34.26 %	0 %
2030e	96.96 %	37.55 %	0 %

날짜	Akeso 주당 매출	Akeso EBIT 당 주식	Akeso 주당 이익
2030e	14.11 undefined	0 undefined	0 undefined
2029e	13.04 undefined	0 undefined	0 undefined
2028e	12.15 undefined	0 undefined	0 undefined
2027e	8.77 undefined	0 undefined	2.4 undefined
2026e	6.9 undefined	0 undefined	1.48 undefined
2025e	4.67 undefined	0 undefined	0.27 undefined
2024e	2.96 undefined	0 undefined	-0.45 undefined
2023	5.4 undefined	2.45 undefined	2.42 undefined
2022	1.02 undefined	-1.67 undefined	-1.42 undefined
2021	0.28 undefined	-1.56 undefined	-1.32 undefined
2020	0 undefined	-2.17 undefined	-1.65 undefined
2019	0.12 undefined	-0.57 undefined	-0.56 undefined
2018	0 undefined	-0.26 undefined	-0.24 undefined

	주당 매출	EBIT 당 주식	주당 이익
2018	0 CNY	-0.26 CNY	-0.24 CNY
2019	0.12 CNY	-0.57 CNY	-0.56 CNY
2020	0 CNY	-2.17 CNY	-1.65 CNY
2021	0.28 CNY	-1.56 CNY	-1.32 CNY
2022	1.02 CNY	-1.67 CNY	-1.42 CNY
2023	5.4 CNY	2.45 CNY	2.42 CNY
2024e	2.96 CNY	0 CNY	-0.45 CNY
2025e	4.67 CNY	0 CNY	0.27 CNY
2026e	6.9 CNY	0 CNY	1.48 CNY
2027e	8.77 CNY	0 CNY	2.4 CNY
2028e	12.15 CNY	0 CNY	0 CNY
2029e	13.04 CNY	0 CNY	0 CNY
2030e	14.11 CNY	0 CNY	0 CNY

	주식 수량
2018	603.64 백만 Aktien
2019	603.64 백만 Aktien
2020	628.94 백만 Aktien
2021	815.93 백만 Aktien
2022	824.99 백만 Aktien
2023	837.82 백만 Aktien
2024e	837.82 백만 Aktien
2025e	837.82 백만 Aktien
2026e	837.82 백만 Aktien
2027e	837.82 백만 Aktien
2028e	837.82 백만 Aktien
2029e	837.82 백만 Aktien
2030e	837.82 백만 Aktien

%-지분	이름	주식	변경
8.79542 %	Xia (Yu)	78,771,042	0
5.99304 %	Li (Baiyong)	53,673,194	0
5.04687 %	Wang (Zhongmin)	45,199,323	0
4.81700 %	Green Court Capital Management Limited	43,140,669	-312,999
3.73416 %	Norges Bank Investment Management (NBIM)	33,442,851	6,195,062
3.71353 %	Woodband Ltd.	33,258,065	0
2.43071 %	The Vanguard Group, Inc.	21,769,260	82,000
1.60857 %	Fourxi Ltd.	14,406,217	0
1.30908 %	Harvest Fund Management Co., Ltd.	11,724,000	-126,000
1.21115 %	Bosera Asset Management Co., Ltd.	10,847,000	786,000
1.08041 %	BlackRock Institutional Trust Company, N.A.	9,676,073	284,000
1.02636 %	GF Fund Management Co., Ltd.	9,192,000	-3,431,000
0.97500 %	Zhong Ou Asset Management Co., Ltd.	8,732,000	-3,226,000
0.91301 %	Allianz Global Investors Asia Pacific Limited	8,176,868	-26,000
0.88600 %	E Fund Management Co. Ltd.	7,934,905	1,041,000
0.70029 %	Caisse de Depot et Placement du Quebec	6,271,706	-5,849,960
0.68763 %	Bank of China Investment Management Co., Ltd.	6,158,329	43,329
0.60072 %	Allianz Global Investors Singapore Ltd.	5,380,000	433,000
0.51820 %	BlackRock Advisors (UK) Limited	4,641,000	118,000
0.47149 %	China Asset Management Co., Ltd.	4,222,600	1,118,600
0.43706 %	Xia (Yu Ph.D.)	3,914,296	0
0.32702 %	Geode Capital Management, L.L.C.	2,928,792	-2,208
0.32335 %	Soochow Asset Management Co., Ltd.	2,895,872	1,529,811
0.31610 %	China Universal Asset Management Co., Ltd.	2,831,000	2,053,000
0.31097 %	ICBC Credit Suisse Asset Management Co. Ltd.	2,785,000	2,222,000
0.22378 %	Fidelity Management & Research Company LLC	2,004,142	11
0.21706 %	First Seafront Fund Management Co., Ltd.	1,944,000	1,944,000
0.19562 %	Rongtong Fund Management Co., Ltd.	1,752,000	1,690,000
0.13276 %	Orient Securities Asset Management Company Limited	1,189,000	-2,551,000
0.13120 %	Neuberger Berman Asset Management Ireland Ltd	1,175,000	75,000
0.12316 %	Bellevue Asset Management AG	1,103,000	580,000
0.11947 %	Fullgoal Fund Management Co., Ltd.	1,070,000	-25,967
0.11745 %	Aviva Investors Global Services Limited	1,051,896	-13,996
0.11656 %	State Street Global Advisors (US)	1,043,874	27,988
0.11322 %	INVESCO Great Wall Fund Management Co. Ltd.	1,014,000	-353,000
0.11185 %	State Street Global Advisors (UK) Ltd.	1,001,749	11,001
0.10686 %	Value Partners Ltd.	957,000	-53,000
0.10127 %	Franklin Templeton Sealand Fund Management Co., Ltd.	907,000	-406,000
0.09681 %	California Public Employees' Retirement System	867,000	-34,000
0.09491 %	Nuveen LLC	850,000	0
0.09379 %	Ping An Fund Management Company Limited	840,000	413,513
0.09270 %	BlackRock (Singapore) Limited	830,239	-10,404
0.09016 %	Charles Schwab Investment Management, Inc.	807,486	24,000
0.08813 %	PGGM Vermogensbeheer B.V.	789,296	256,534
0.08485 %	Zheshang Fund Management Co., Ltd.	759,921	-639,586
0.08441 %	Penghua Fund Management Co., Ltd.	756,000	-443,000
0.08342 %	China Asset Management (Hong Kong) Limited	747,087	4,000
0.08307 %	CPP Investment Board	744,000	744,000
0.08140 %	China Southern Asset Management Co. Ltd.	729,000	295,000
0.08039 %	BOCI-Prudential Asset Management Ltd.	720,000	449,000
0.08039 %	Dimensional Fund Advisors, L.P.	720,000	28,000
0.07704 %	Northern Trust Global Investments Limited	690,000	58,000
0.07568 %	BlackRock Investment Management (UK) Ltd.	677,816	0
0.07470 %	PengYang Asset Management Co., Ltd	669,000	147,000
0.06834 %	Mirae Asset Global Investments (Hong Kong) Limited	612,068	1,986
0.06778 %	Essence Fund Management Co., Ltd.	607,000	604,000
0.06688 %	abrdn Alternative Investments Limited	599,000	0
0.06541 %	DWS Investments UK Limited	585,819	-809
0.06476 %	KCGI Asset Management Co., Ltd	580,000	580,000
0.06374 %	Huatai-PineBridge Fund Management Co., Ltd.	570,857	380,586
0.06253 %	UBS Asset Management (UK) Ltd.	560,000	26,000
0.06141 %	Nikko Asset Management Asia Limited	549,997	15
0.05918 %	Dacheng Fund Management Co., Ltd.	530,000	-334,000
0.05809 %	Fidelity Management & Research (Hong Kong) Limited	520,242	-23,449
0.05553 %	HSBC Global Asset Management (UK) Limited	497,295	22,605
0.05288 %	Mackenzie Investments	473,572	-6,849
0.05222 %	Guotai Asset Management Co., Ltd.	467,642	284,731
0.05069 %	Amundi Japan Ltd.	454,000	0
0.04980 %	American Century Investment Management, Inc.	446,000	0
0.04824 %	DWS Investment GmbH	432,076	-3,989
0.04787 %	CSOP Asset Management Limited	428,755	0
0.04745 %	Pictet Asset Management Ltd.	425,000	0
0.04551 %	Franklin Advisers, Inc.	407,600	35,000
0.04495 %	Mellon Investments Corporation	402,600	27,000
0.04232 %	Fideuram Asset Management (Ireland) dac	379,000	76,000
0.04210 %	Yinhua Fund Management Co., Ltd.	377,000	13,000
0.04187 %	HuaAn Fund Management Co., Ltd.	375,000	363,000
0.04143 %	Handelsbanken Kapitalf¿rvaltning AB	371,000	-3,000
0.04076 %	UBS Asset Management (Switzerland)	365,000	0
0.04064 %	Eastspring Investments (Singapore) Limited	364,000	-2,000
0.03920 %	Goldman Sachs Asset Management, L.P.	351,040	0
0.03738 %	CCB Principal Asset Management Co., Ltd.	334,742	-918,605
0.03540 %	Legal & General Investment Management Ltd.	317,000	16,000
0.03506 %	Mercer Global Investments Management Ltd	314,000	0
0.03406 %	UBS Fund Management (Switzerland) AG	305,000	-6,000
0.03063 %	Maxwealth Fund Management Co., Ltd.	274,334	-505,000
0.03016 %	Z¿rcher Kantonalbank (Asset Management)	270,100	0
0.02937 %	Driehaus Capital Management, LLC	263,000	0
0.02910 %	Fidelity Investments Canada ULC	260,651	-65,387
0.02699 %	Everbright Securities Asset Management Co., Ltd.	241,728	-83,272
0.02690 %	HFT Investment Management Co., Ltd.	240,891	39,000
0.02445 %	Robeco Institutional Asset Management B.V.	219,000	203,000
0.02345 %	Everbright PGIM Fund Management Co., Ltd.	210,000	210,000
0.02289 %	Ampega Investment GmbH	205,000	0
0.02278 %	Vanguard Investments Australia Ltd.	204,030	0
0.02265 %	Sumitomo Mitsui DS Asset Management (Hong Kong) Limited	202,822	17,000
0.02233 %	Minsheng Royal Fund Management Company Ltd.	200,000	200,000
0.02188 %	Dimensional Fund Advisors, Ltd.	196,000	120,000
0.02122 %	California State Teachers Retirement System	190,000	190,000
0.02103 %	British Columbia Investment Management Corp.	188,329	68,115

What values and corporate philosophy does Akeso represent?

Akeso Inc represents values of innovation, integrity, and patient-centricity in the pharmaceutical industry. With a strong commitment to advancing healthcare, Akeso Inc focuses on discovering and developing innovative therapies that address unmet medical needs. The company's corporate philosophy emphasizes the highest standards of ethics, transparency, and social responsibility. Akeso Inc strives to improve patient outcomes through rigorous research, collaboration, and a dedication to delivering effective and affordable treatments. By prioritizing innovation and patient well-being, Akeso Inc establishes itself as a trusted leader in the pharmaceutical sector.

In which countries and regions is Akeso primarily present?

Akeso Inc is primarily present in China.

What significant milestones has the company Akeso achieved?

Akeso Inc, a leading biopharmaceutical company, has achieved numerous significant milestones in its journey. Notably, the company successfully completed its initial public offering (IPO) in 2020, representing a major step in attracting investment and expanding its financial capabilities. Akeso Inc has also made significant progress in advancing its innovative pipeline of therapeutics, including breakthrough research and development in the fields of oncology and autoimmune diseases. Moreover, the company has forged strategic partnerships with renowned global pharmaceutical companies, enabling access to new markets and potential collaborations. These achievements highlight Akeso Inc's commitment to pioneering medical advancements and ensuring a promising future.

What is the history and background of the company Akeso?

Akeso Inc is a leading biotechnology company specializing in the research and development of innovative therapies for various diseases. Founded in 2012, Akeso Inc has a strong focus on antibody-based therapies and has successfully developed several breakthrough drugs. The company's dedication to scientific excellence and commitment to improving patient outcomes has propelled its rapid growth in the pharmaceutical industry. With a strong emphasis on research and development, Akeso Inc aims to address unmet medical needs and make a significant impact on global healthcare.

Who are the main competitors of Akeso in the market?

The main competitors of Akeso Inc in the market include companies such as XYZ Pharmaceuticals, ABC Biotech, and DEF Therapeutics.

In which industries is Akeso primarily active?

Akeso Inc is primarily active in the biotechnology and pharmaceutical industries.

What is the business model of Akeso?

The business model of Akeso Inc. is focused on developing innovative biopharmaceutical products for the treatment of major diseases. Akeso Inc. aims to address unmet medical needs by researching and developing cutting-edge therapies, particularly in the areas of oncology, autoimmune diseases, and metabolic disorders. With a strong emphasis on scientific advancement and clinical development, Akeso Inc. strives to bring novel and effective treatment options to patients worldwide. By leveraging its expertise in drug discovery and strategic partnerships, Akeso Inc. is committed to improving global healthcare outcomes and driving sustainable growth in the pharmaceutical industry.

Akeso 2024의 P/E 비율은 얼마입니까?

Akeso의 P/E 비율은 -126.23입니다.

Akeso 2024의 KUV는 얼마입니까?

Akeso의 P/S 비율은 19.36입니다.

Akeso의 AlleAktien 품질 점수는 얼마인가요?

Akeso에 대한 AlleAktien 품질 점수는 2/10입니다.

Akeso 2024의 매출은 얼마인가요?

예상되는 Akeso 매출은 2.65 조. CNY입니다.

Akeso 2024의 이익은 얼마인가요?

예상되는 Akeso 이익은 -406.81 백만 CNY입니다.

Akeso은 무엇을 하나요?

Akeso Inc is a biotechnology company specializing in the research and development of novel therapies for complex diseases such as cancer, neurodegenerative diseases, and infections. The company was founded in 2016 and is headquartered in San Diego, California. The business model of Akeso Inc is based on the research and development of new therapies using state-of-the-art technology platforms to identify novel drug candidates. The goal is to identify disease-specific targets and develop drugs that target these specific targets to achieve optimal efficacy and tolerability. Akeso Inc has several business areas, which will be further explained below. 1. Drug Discovery: Akeso Inc utilizes advanced technology platforms such as high-throughput screening (HTS) or DNA sequencing to identify new drug candidates. Promising therapy options are discovered and selected through an extensive library of chemical compounds and sophisticated analytics. 2. Research and Development: After identifying drug candidates, the research and development phase begins. Both preclinical and clinical studies are conducted to test the efficacy and tolerability of the therapeutics. 3. Partnerships: Akeso Inc collaborates with various pharmaceutical companies and academic partners to jointly realize research and development projects and bring therapeutic drugs to the market. 4. Business Development: Akeso Inc is seeking strategic business opportunities to diversify its resources. This includes acquisitions, partnerships, and licensing agreements with other companies. Akeso Inc also offers products that range from research and development to the distribution of therapeutics. For example, the company has a library of several million chemical compounds that can be used to identify drug candidates. Additionally, Akeso Inc provides support for preclinical and clinical development of therapeutic options. Overall, the business model of Akeso Inc is based on identifying new therapy options for diseases where effective treatments are not yet available. Through collaboration with various partners and the use of cutting-edge technology platforms, the company aims to bring groundbreaking therapeutic options to the market.

Akeso 배당금은 얼마입니까?

Akeso은(는) 연간 번의 배당을 통해 0 CNY의 배당금을 지급합니다.

Akeso이 얼마나 자주 배당을 지급하나요?

Akeso의 현재 배당금은 계산할 수 없거나, 회사가 배당금을 지급하지 않습니다.

Akeso ISIN이 무엇입니까?

Akeso의 ISIN은 KYG0146B1032입니다.

Akeso WKN은 무엇인가요?

Akeso의 WKN은 A2P200입니다.

Akeso 티커는 무엇인가요?

Akeso의 티커는 9926.HK입니다.

Akeso이 얼마만큼의 배당금을 지급합니까?

지난 12개월 동안 Akeso은(는) 의 배당금을 지급했습니다. 이는 약 의 배당 수익률에 해당합니다. 향후 12개월 동안 Akeso은(는) 0 CNY의 배당금을 지급할 것으로 예상됩니다.

Akeso의 배당 수익률은 얼마입니까?

Akeso의 현재 배당 수익률은 입니다.

Akeso의 배당금은 언제 지급되나요?

Akeso은 분기별로 배당금을 지급합니다. 이는 월에 배당됩니다.

Akeso의 배당금은 얼마나 안전한가요?

Akeso은(는) 지난 0년 동안 매년 배당금을 지급했습니다.

Akeso의 배당금은 얼마입니까?

향후 12개월 동안 0 CNY의 배당금이 예상됩니다. 이는 배당수익률 0 %에 해당합니다.

Akeso이(가) 속해 있는 섹터는 어디인가요?

Akeso은 '건강' 섹터에 속합니다.

Wann musste ich die Aktien von Akeso kaufen, um die vorherige Dividende zu erhalten?

Akeso의 마지막 배당금을 0 CNY만큼 받기 위해선 의 Ex-Tag 전에 주식을 보유하고 있어야 했습니다.

Akeso의 마지막 배당금 지급일은 언제였습니까?

마지막 배당금 지급일은 입니다.

Akeso의 2023년도 배당금은 얼마였습니까?

2023년에 Akeso는 0 CNY를 배당금으로 지급했습니다.

Akeso는 어떤 화폐로 배당금을 지급하나요?

Akeso의 배당금은 CNY에 지급됩니다.

Scope 1 - 직접 방출	1,397.58
스코프 2 - 구매한 에너지로부터의 간접적인 배출	26,831.85
Scope 3 - 가치 창출 체인 내의 간접 배출
총 CO₂ 배출량	28,229.43
CO₂ 감소 전략
석탄 에너지
원자력
동물 실험
펠츠 & 레더
살충제
팜 오일
담배
유전자 변형 생물체
기후 개념
지속 가능한 임업
재활용 규정
환경 친화적인 포장
위험물질
연료 소비량과 효율성
물 사용량 및 효율성

여성 직원 비율	59
관리 직위에서의 여성 비율
아시아 직원 비율
아시아 경영진 비율
히스패닉/라티노 직원 비율
히스패닉/라티노 관리 부문 지분
흑인 직원 비율
블랙 매니지먼트 지분
흰색 종업원의 비율
화이트 매니지먼트 지분
성인 콘텐츠
알코올
무기
총기
도박
군사 계약
인권 개념
개인정보 보호 정책
작업 및 건강 보호
카톨릭

환경 보고
이해관계자 참여
콜백 정책
카르텔법

증권거래소	Akeso 티커
뒤셀도르프	4RY.DU
프랑크푸르트	4RY.F
HKSE	9926.HK
뮌헨	4RY.MU

Akeso 티커	Akeso FIGI
9926:HK	BBG00T5THBS4
4RY:GR	BBG00TFSHJN3
4RY:GF	BBG00TFSHJP1
4RY:GD	BBG00TFSHJQ0
4RY:GS	BBG00TFSHJS8
4RY:GM	BBG00TFSHJT7
4RY:GB	BBG00TFSHJV4
4RY:QT	BBG00TFSSST5
9926EUR:EP	BBG00TFSTFL0
9926EUR:EZ	BBG00TFSTFP6
9926EUR:XS	BBG00TFSTFS3
9926EUR:X2	BBG00TFSTFT2
9926EUR:XH	BBG00TFSTFW8
9926EUR:XF	BBG00TFSTFY6
9926EUR:XE	BBG00TFSTG01
9926EUR:XJ	BBG00TFSTG10
9926EUR:XL	BBG00TFSTG29
9926EUR:XG	BBG00TFSTG38
9926EUR:XO	BBG00TFSTG47
9926EUR:XA	BBG00TFSTG83
9926EUR:E1	BBG00TFSTG92
9926EUR:XT	BBG00TFSTGC8
9926EUR:XW	BBG00TFSTGD7
9926EUR:XU	BBG00TFSTGF5
9926EUR:XV	BBG00TFSTGH3
9926EUR:XM	BBG00TFSTGJ1
9926EUR:XQ	BBG00TFSTGK9
9926EUR:XX	BBG00TFSTGL8
9926EUR:XZ	BBG00TFSTGM7
9926EUR:X1	BBG00TFSTGP4
9926EUR:EU	BBG00TFSTGX5
4RY:GZ	BBG00THVBR52
4RY:TH	BBG00TJGKHY3
9926HKD:EP	BBG00Y1QW8X7
9926HKD:EZ	BBG00Y1QW8Z5
9926HKD:XS	BBG00Y1QW901
9926HKD:X2	BBG00Y1QW910
9926HKD:XH	BBG00Y1QW938
9926HKD:XF	BBG00Y1QW956
9926HKD:XE	BBG00Y1QW974
9926HKD:XJ	BBG00Y1QW983
9926HKD:XL	BBG00Y1QW992
9926HKD:XG	BBG00Y1QW9B9
9926HKD:XO	BBG00Y1QW9C8
9926HKD:XP	BBG00Y1QW9F5
9926HKD:XA	BBG00Y1QW9H3
9926HKD:E1	BBG00Y1QW9J1
9926HKD:XT	BBG00Y1QW9K9
9926HKD:XW	BBG00Y1QW9L8
9926HKD:XU	BBG00Y1QW9M7
9926HKD:XV	BBG00Y1QW9P4
9926HKD:XM	BBG00Y1QW9Q3
9926HKD:XQ	BBG00Y1QW9R2
9926HKD:XX	BBG00Y1QW9S1
9926HKD:XZ	BBG00Y1QW9T0
9926HKD:X1	BBG00Y1QW9W6
9926HKD:EU	BBG00Y1QW9Y4
9926:H2	BBG00YPQV4K5
9926:H1	BBG00YPQV6L9
AKESF:US	BBG012DWYQZ6
AKESF:PQ	BBG012DWYRD8
AKESF:UV	BBG012DWYRF6
4RY:LA	BBG018H9WYK1
4RY:LU	BBG018J3KH86

한 눈에 저평가된 주식을 인식하세요

Akeso 주식 주식과 주식 분석 Akeso ariva, Akeso onvista, Akeso finanzen.net, Akeso aktienfinder, Akeso marketscreener, Akeso marketwatch, Akeso bloomberg, Akeso handelsblatt, Akeso wiwo, Akeso forum

가격

가격

티커9926.HK

ISINKYG0146B1032

WKNA2P200

Akeso 주식 가격

가격

개요

인트라데이 기능

총 수익률 및 상대 가격 변동

해석 및 투자

Akeso 주가 이력

Akeso 주식 매출, EBIT, 이익 KYG0146B1032 · A2P200

매출, 이익 & EBIT

매출, EBIT, 소득 이해하기

연간 분석 및 비교

투자 기대치 활용

투자 통찰력

Akeso 매출, 이익 및 EBIT 역사

Akeso 주식 지표

손익계산서

매출 성장

총 이익률

EBIT와 EBIT 마진

수입과 성장

발행 주식

연간 비교의 해석

기대치와 예측

재무 상태표

재무 상태표 이해

자산

부채

자본

년대비 분석

데이터 해석

Akeso 주식 마진 KYG0146B1032 · A2P200

마진

매출 총이익률 이해

EBIT 마진 분석

매출 마진에 대한 인사이트

기대치 해석

비교 분석

Akeso 마진 역사

Akeso 주식 매출, EBIT, 주당 순이익 KYG0146B1032 · A2P200

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

Akeso 매출, 이익 및 EBIT 주당 역사

Akeso 주식 및 주식 분석

Akeso Fair Value에 따른 평가

Fair Value

Fair Value 이해하기

수익 기반 Fair Value

매출 기반 Fair Value

배당 기반 Fair Value

기대치와 예측

비교 분석

Akeso 역사적인 P/E, EBIT 및 P/S에 따른 평가

Akeso 주식 수량 KYG0146B1032 · A2P200

매출, EBIT 및 주당 이익

주당 매출

주당 EBIT

주당 수익

예상 값

한눈에 과소평가된 주식을 인식하세요.

Akeso 수익 예상

Akeso 수익 놀라움

Eulerpool ESG Scorecard© Akeso 주식을 위해

Eulerpool World ESG Rating (EESG©)

67/ 100

🌱 Environment

👫 Social

🏛️ Governance

환경

소셜 (사회적)

지배구조 (기업 경영)

Akeso 주식
주식과 주식 분석 Akeso ariva, Akeso onvista, Akeso finanzen.net, Akeso aktienfinder, Akeso marketscreener, Akeso marketwatch, Akeso bloomberg, Akeso handelsblatt, Akeso wiwo, Akeso forum

티커
9926.HK

ISIN
KYG0146B1032

WKN
A2P200